<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ini.sagepub.com">
<title>Innate Immunity recent issues</title>
<link>http://ini.sagepub.com</link>
<description>Innate Immunity RSS feed -- recent issues</description>
<prism:publicationName>Innate Immunity</prism:publicationName>
<prism:issn>1753-4259</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/5/261?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/5/313?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/4/195?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/4/205?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/4/217?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/4/225?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/4/233?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/4/243?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/4/251?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/3/131?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/3/143?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/3/155?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/3/169?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/3/179?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/2/67?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/2/81?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/2/91?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/2/101?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/2/109?rss=1" />
  <rdf:li rdf:resource="http://ini.sagepub.com/cgi/content/abstract/15/2/121?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://ini.sagepub.com:80/icons/banner/title.gif" />
</channel>

<image rdf:about="http://ini.sagepub.com:80/icons/banner/title.gif">
<title>Innate Immunity</title>
<url>http://ini.sagepub.com:80/icons/banner/title.gif</url>
<link>http://ini.sagepub.com</link>
</image>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/5/261?rss=1">
<title><![CDATA[Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/5/261?rss=1</link>
<description><![CDATA[<p>Pseudomonas aeruginosa causes serious nosocomial infections, and an important virulence factor produced by this organism is lipopolysaccharide (LPS). This review summarizes knowledge about biosynthesis of all three structural domains of LPS &mdash; lipid A, core oligosaccharide, and O polysaccharides. In addition, based on similarities with other bacterial species, this review proposes new hypothetical pathways for unstudied steps in the biosynthesis of P. aeruginosa LPS. Lipid A biosynthesis is discussed in relation to Escherichia coli and Salmonella, and the biosyntheses of core sugar precursors and core oligosaccharide are summarised. Pseudomonas aeruginosa attaches a Common Polysaccharide Antigen and O-Specific Antigen polysaccharides to lipid A-core. Both forms of O polysaccharide are discussed with respect to their independent synthesis mechanisms. Recent advances in understanding O-polysaccharide biosynthesis since the last major review on this subject, published nearly a decade ago, are highlighted. Since P. aeruginosa O polysaccharides contain unusual sugars, sugar-nucleotide biosynthesis pathways are reviewed in detail. Knowledge derived from detailed studies in the O5, O6 and O11 serotypes is applied to predict biosynthesis pathways of sugars in poorly-studied serotypes, especially O1, O4, and O13/O14. Although further work is required, a full understanding of LPS biosynthesis in P. aeruginosa is almost within reach.</p>]]></description>
<dc:creator><![CDATA[King, J. D., Kocincova, D., Westman, E. L., Lam, J. S.]]></dc:creator>
<dc:date>Tue, 06 Oct 2009 06:26:25 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425909106436</dc:identifier>
<dc:title><![CDATA[Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>312</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>261</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/5/313?rss=1">
<title><![CDATA[Class C CpG oligodeoxynucleotides as a single agent and in combination with radiotherapy efficiently delayed growth of subcutaneous B16F1 tumors]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/5/313?rss=1</link>
<description><![CDATA[<p>Until now, the anti-tumor efficacy of synthetic oligodeoxynucleotides containing CpG motifs (CpG ODNs) has been reported in a number of preventive and therapeutic tumor models. Predominately class B CpG ODNs were used, relatively little has been reported regarding the class C CpG ODNs. The present study was, therefore, aimed at assessing the ability of CpG ODNs class C applied as a single agent and in combination with radiotherapy to induce the anti-tumor immunity in an experimental tumor model in mice (subcutaneous [s.c.] B16F1). Class C CpG ODNs applied three times as a single agent efficiently delayed the growth of s.c. B16F1 tumors. The combined therapy (CpG ODNs and tumor irradiation) remarkably enhanced the anti-tumor effect. The peritumoral (p.t.) application of CpG ODNs in combination with irradiation increased the number of dendritic cells (DCs) at the tumor site and improved the antigen loading and maturation of DCs. In conclusion, the combined therapy with CpG ODNs and irradiation creates a unique in situ DCs vaccine that could be easily applicable without prior knowledge of tumor antigens.</p>]]></description>
<dc:creator><![CDATA[Cerkovnik, P., Jezersek Novakovic, B., Stegel, V., Novakovic, S.]]></dc:creator>
<dc:date>Tue, 06 Oct 2009 06:26:25 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425909105581</dc:identifier>
<dc:title><![CDATA[Class C CpG oligodeoxynucleotides as a single agent and in combination with radiotherapy efficiently delayed growth of subcutaneous B16F1 tumors]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>5</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>321</prism:endingPage>
<prism:publicationDate>2009-10-01</prism:publicationDate>
<prism:startingPage>313</prism:startingPage>
<prism:section>Articles</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/4/195?rss=1">
<title><![CDATA[Detection and quantification of five major periodontal pathogens by single copy gene-based real-time PCR]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/4/195?rss=1</link>
<description><![CDATA[<p>Periodontitis is a common chronic multibacterial infection in the tooth-supporting tissues. It has been shown that periodontitis patients carry higher number of disease-associated bacteria than healthy ones. The aim of this study was to generate a novel, single copy gene-based quantitative real-time PCR (qPCR) assay for five major periodontal pathogens &mdash; Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Treponema denticola, and Tannerella forsythia. The primer/probe sets were designed for conservative lipopolysaccharide-coding gene regions. They proved to be sensitive and able to detect strains representing different serotypes of the target bacteria. The specificity of designed primers was tested using 49 selected bacterial species and no false positive or negative results were observed. We validated the assay with a case-control population, including 165 saliva samples, and proved the diagnostic accuracy by Receiver Operating Characteristic (ROC) curves. All quantified pathogens alone were able to distinguish significantly between the subjects with and without periodontitis, and provided areas under the ROC curve larger than 0.5. The total pathogen burden comprising all five species associated with periodontitis with an area of 0.821 (95% CI, 0.758&mdash;0.885, P50.001). Our prominently sensitive and specific assay may have major importance in the diagnosis, prevention, and treatment of periodontitis.</p>]]></description>
<dc:creator><![CDATA[Hyvarinen, K., Laitinen, S., Paju, S., Hakala, A., Suominen-Taipale, L., Skurnik, M., Kononen, E., Pussinen, P. J.]]></dc:creator>
<dc:date>Mon, 27 Jul 2009 08:06:25 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425908101920</dc:identifier>
<dc:title><![CDATA[Detection and quantification of five major periodontal pathogens by single copy gene-based real-time PCR]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>204</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>195</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/4/205?rss=1">
<title><![CDATA[TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/4/205?rss=1</link>
<description><![CDATA[<p>Otitis media is the most prevalent childhood disease in developed countries. The involvement of Toll-like receptors (TLRs) in otitis media pathophysiology has been implicated by studies in cell lines and association studies of TLR gene polymorphisms. However, precise functions of TLRs in the etiology of otitis media in vivo have not been examined. We investigated the inflammatory response to nontypeable Haemophilus influenzae using a model of otitis media in wild-type, TLR2<sup>&mdash; /&mdash;</sup> and TLR4<sup>&mdash;/ &mdash;</sup> mice by gene microarray, qPCR, immunohistochemistry, Western blot analysis and histopathology. Toll-like receptor-2<sup>&mdash; /&mdash;</sup> and TLR4<sup>&mdash; /&mdash;</sup> mice exhibited a more profound, persistent inflammation with impaired bacterial clearance compared to controls. While wild-type mice induced tumor necrosis factor-a (TNF) after non-typeable H. influenzae challenge, TLR2<sup>&mdash;/&mdash;</sup> and TLR4<sup>&mdash;/&mdash;</sup> mice lack TNF induction in the early phase of otitis media. Moreover, lack of TLR2 resulted in a late increase in IL-10 expression and prolonged failure to clear bacteria. Toll-like receptor-4<sup>&mdash;/&mdash; </sup> mice showed impaired early bacterial clearance and loss of TLR2 induction in early otitis media. Our results demonstrate that both TLR2 and TLR4 signalling are critical to the regulation of infection in non-typeable H. influenzae-induced otitis media. Toll-like receptor-4 signalling appears to induce TLR2 expression, and TLR2 activation is critical for bacterial clearance and timely resolution of otitis media.</p>]]></description>
<dc:creator><![CDATA[Leichtle, A., Hernandez, M., Pak, K., Yamasaki, K., Cheng, C.-F., Webster, N. J., Ryan, A. F., Wasserman, S. I.]]></dc:creator>
<dc:date>Mon, 27 Jul 2009 08:06:25 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425909103170</dc:identifier>
<dc:title><![CDATA[TLR4-mediated induction of TLR2 signaling is critical in the pathogenesis and resolution of otitis media]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>215</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>205</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/4/217?rss=1">
<title><![CDATA[Interleukin (IL)-10 attenuates lipopolysaccharide-induced IL-6 production via inhibition of I{kappa}B-{zeta} activity by Bcl-3]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/4/217?rss=1</link>
<description><![CDATA[<p>The inhibitory effect of interleukin-10 (IL-10), an anti-inflammatory cytokine, on lipopolysaccharide (LPS)-induced IL-6 production was characterized by simultaneous stimulation of RAW 264.7 cells with LPS and IL-10. The presence of IL-10 significantly inhibited LPS-induced IL-6 production at a transcriptional level. The expression of IB-, which promotes IL-6 production, was induced in response to LPS and it was definitely suppressed in the presence of IL-10. Further, IL-10 inhibited LPS-induced NF-B activation. A pharmacological inhibitor of NF-B prevented LPS-induced IB- expression, suggesting that IL-10 might inhibit LPS-induced IB- expression via the inactivation of NF-B. In LPS- and IL-10-stimulated cells, the expression of Bcl-3 that inhibits NF-B activation was significantly augmented. Introduction of Bcl-3 siRNA abolished IL-10-mediated IB- inhibition. In the presence of Bcl-3, siRNA IL-10 failed to inhibit LPS-induced IL-6 production. Therefore, it was suggested that Bcl-3 induced by IL-10 might reduce LPS-induced IB- activity via inactivation of NF-B and that reduced IB- activity failed to promote LPS-induced IL-6 production.</p>]]></description>
<dc:creator><![CDATA[Dagvadorj, J., Naiki, Y., Tumurkhuu, G., Abu Shadat Mohammod Noman,  , Iftekar-E-Khuda, I., Koide, N., Komatsu, T., Yoshida, T., Yokochi, T.]]></dc:creator>
<dc:date>Mon, 27 Jul 2009 08:06:25 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425909103738</dc:identifier>
<dc:title><![CDATA[Interleukin (IL)-10 attenuates lipopolysaccharide-induced IL-6 production via inhibition of I{kappa}B-{zeta} activity by Bcl-3]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>224</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>217</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/4/225?rss=1">
<title><![CDATA[NOD1 gene polymorphisms in relation to aggressive periodontitis]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/4/225?rss=1</link>
<description><![CDATA[<p>Background: NOD proteins are part of innate immunity mechanisms. They play a role in epithelial barrier functions and inflammatory responses to bacteria. Single nucleotide polymorphisms (SNPs) in the NOD1 gene have proven to be associated with inflammatory bowel disease (IBD) and asthma.</p><p>Objective: To investigate SNPs in the NOD1 gene in relation to aggressive periodontitis (AgP), a multifactorial, inflammatory disease of the supporting tissues of the teeth.</p><p>Materials and Methods: Five SNPs in the NOD1 gene (4 intronic and 1 exonic) were tested for association in a total of 415 AgP patients and 874 controls both of Northern European ancestry.</p><p>Results: The frequencies of the rare SNP alleles ranged between 21% and 26% among cases, and 20&mdash;27% among controls, and were not statistically different between cases and controls. Two SNPs were in strong linkage disequilibrium (r<sup>2</sup> = 0.97 in cases and 0.94 in controls). The overall haplotype distributions did not differ between cases and controls. We observed 8 haplotypes with a frequency of !1% among cases and/or controls, but none of these haplotype frequencies differed significantly among cases and controls. Logistic regression analyses with adjustment for gender and smoking status did not reveal significant associations with AgP for any of the 5 SNPs. This study had a power of !95% to detect associations with variants carrying relative risks of !1.5 for heterozygote carriers and !2.25 for homozygote carriers.</p><p>Conclusions: Although SNPs in the NOD1 gene have been strongly associated with cases of IBD, the current study failed to show an association of NOD1 SNPs with AgP.</p>]]></description>
<dc:creator><![CDATA[Loos, B.G., Fiebig, A., Nothnagel, M., Jepsen, S., Groessner-Schreiber, B., Franke, A., Jervoe-Storm, P.M., Schenck, K., van der Velden, U., Schreiber, S.]]></dc:creator>
<dc:date>Mon, 27 Jul 2009 08:06:25 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425909103739</dc:identifier>
<dc:title><![CDATA[NOD1 gene polymorphisms in relation to aggressive periodontitis]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>232</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>225</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/4/233?rss=1">
<title><![CDATA[The potential role of T-cells and their interaction with antigen-presenting cells in mediating immunosuppression following trauma-hemorrhage]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/4/233?rss=1</link>
<description><![CDATA[<p>Objective: Trauma-hemorrhage results in depressed immune responses of antigen-presenting cells (APCs) and T-cells. Recent studies suggest a key role of depressed T-cell derived interferon (IFN)-g in this complex immune cell interaction. The aim of this study was to elucidate further the underlying mechanisms responsible for dysfunctional T-cells and their interaction with APCs following trauma-hemorrhage.</p><p>Design: Adult C3H/HeN male mice were subjected to trauma-hemorrhage (3-cm midline laparotomy) followed by hemorrhage (blood pressure of 35 &plusmn; 5 mmHg for 90 min and resuscitation) or sham operation. At 24 h thereafter, spleens were harvested and T-cells (by Microbeads) and APCs (via adherence) were Isolated. Co-cultures of T-cells and APCs were established for 48 h and stimulated with concanavalin A and lipopolysaccharide. T-Cell specific cytokines known to affect APC function (i.e. interleukin(IL)-2, IL-4 and granulocyte-macrophage colony-stimulating factor (GM-CSF)) were measured in culture supernatants by Multiplex assay. The expression of MHC class II as well as co-stimulatory surface molecules on T-cells and APCs was determined by flow cytometry.</p><p>Results: The release of IL-4 and GM-CSF by T-cells was suppressed following trauma-hemorrhage, irrespective of whether sham or trauma-hemorrhage APCs were present. Antigen-presenting cells from animals subjected to trauma-hemorrhage did not affect T-cell derived cytokine release by sham T-cells. In contrast, T-cells from trauma-hemorrhage animals depressed MHC class II expression of CD11c(+) cells, irrespective of whether APCs underwent sham or trauma-hemorrhage procedure. Surprisingly, co-stimulatory molecules on APCs (CD80, CD86) were not affected by trauma-hemorrhage.</p><p>Conclusions: These results suggest that beside IFN-g other T-cell derived cytokines contribute to immunosuppression following trauma-hemorrhage causing diminished MHC II expression on APCs. Thus, T-cells appear to play an important role in this interaction at the time-point examined. Therapeutic approaches should aim at maintenance of T-cell function and their interaction with APCs to prevent extended immunosuppression following trauma-hemorrhage.</p>]]></description>
<dc:creator><![CDATA[Walz, C. R., Zedler, S., Schneider, C. P., Albertsmeier, M., Loehe, F., Bruns, C. J., Faist, E., Chaudry, I. H., Angele, M. K.]]></dc:creator>
<dc:date>Mon, 27 Jul 2009 08:06:25 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425909104679</dc:identifier>
<dc:title><![CDATA[The potential role of T-cells and their interaction with antigen-presenting cells in mediating immunosuppression following trauma-hemorrhage]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>241</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>233</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/4/243?rss=1">
<title><![CDATA[Lipopolysaccharide induces alteration of serotonin transporter in human intestinal epithelial cells]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/4/243?rss=1</link>
<description><![CDATA[<p>Intestinal serotoninergic activity and serotonin transporter (SERT) function have been shown to be altered in intestinal inflammatory diseases. Serotonin (5-HT) plays a critical role in the regulation of gastrointestinal physiology. Activity of 5-HT depends on its extracellular availability, partly modulated by SERT that transports 5-HT into the cell. Lipopolysaccharide (LPS) is a component of Gram-negative bacteria outer membrane, which acts as a potent activator of the inflammatory system in the intestine. The aim of this work was to determine, in the enterocyte-like cell line Caco-2, whether LPS treatment affects serotoninergic activity by acting on SERT. The results demonstrate that LPS treatment diminishes SERT activity in a dose- and period-dependent way. The kinetic study shows that V<SUB>max</SUB> was significantly reduced after treatment with LPS. The LPS effect on 5-HT uptake was, in part, mediated by protein kinase C (PKC) activation. The molecular expression of SERT revealed that LPS treatment did not affect the mRNA level or the SERT protein content in cell homogenate. The level of SERT protein, however, was reduced on brush border membrane. The LPS effect might be due to an alteration of the intracellular traffic of SERT which may, in part, be mediated by PKC activity.</p>]]></description>
<dc:creator><![CDATA[Mendoza, C., Matheus, N., Iceta, R., Mesonero, J. E., Alcalde, A. I.]]></dc:creator>
<dc:date>Mon, 27 Jul 2009 08:06:25 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425909104781</dc:identifier>
<dc:title><![CDATA[Lipopolysaccharide induces alteration of serotonin transporter in human intestinal epithelial cells]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>250</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>243</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/4/251?rss=1">
<title><![CDATA[Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/4/251?rss=1</link>
<description><![CDATA[<p>It is widely postulated that systemic inflammation related to lung infections is largely caused by cytokine translocation from the lungs into the systemic circulation but there is a paucity of animal models to evaluate this hypothesis. In this proof-of-concept study, we developed a murine model to determine whether interleukin (IL)-6, a primary inflammatory cytokine, translocates following airway exposure to endotoxin. We collected central venous blood from the right atrium and arterial blood from the aorta simultaneously at 4 h and 24 h following intratracheal exposure to endotoxin (25 mg) and measured IL-6 in the serum and broncho-alveolar lavage (BAL) fluid (n = 33 mice). We repeated the experiment following 3 d of treatment with dexamethasone (n = 31 mice). Without stimulation, there was no significant arteriovenous gradient (3 pg/ml with interquartile range [IQR] of 3&mdash;5 pg/ml in arterial versus 18 pg/ml with IQR of 8&mdash;24 pg/ml in venous serum; P = 0.86). A significant arteriovenous difference was observed by 4 h post-exposure to endotoxin (2813 pg/ml with IQR of 1578&mdash;4316 pg/ml in arterial versus 1282 pg/ml with IQR of 778&mdash;2699 pg/ml in venous serum; P50.0001). The rise in the BAL IL-6 levels correlated with the increases in the arterial serum levels (P50.0001). Administration of intraperitoneal dexamethasone for 3 d attenuated the increased arteriovenous gradient. This murine model facilitates the estimation of cytokine translocation across the lungs and evaluation of compounds to modulate this gradient.</p>]]></description>
<dc:creator><![CDATA[Tamagawa, E., Suda, K., Yuan Wei,  , Li Xing,  , Mui, T., Yuexin Li,  , van Eeden, S. F., Man, S.F. P., Sin, D. D.]]></dc:creator>
<dc:date>Mon, 27 Jul 2009 08:06:25 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425909104782</dc:identifier>
<dc:title><![CDATA[Endotoxin-induced translocation of interleukin-6 from lungs to the systemic circulation]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>4</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>258</prism:endingPage>
<prism:publicationDate>2009-08-01</prism:publicationDate>
<prism:startingPage>251</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/3/131?rss=1">
<title><![CDATA[Differential modulation of NF-{kappa}B-mediated pro-inflammatory response in human intestinal epithelial cells by cheY homologues of Vibrio cholerae]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/3/131?rss=1</link>
<description><![CDATA[<p>Vibrio cholerae, the etiological agent of cholera, colonizes the small intestine, produces an enterotoxin and causes acute inflammatory response at intestinal epithelial surface. Chemotaxis and motility greatly influence the infectivity of V. cholerae although the role of chemotaxis genes in V. cholerae pathogenesis is less well understood. Four cheY genes are present in three clusters in the complete genome sequence of V. cholerae. A less motile and less adherent mutant was generated by inactivation of cheY-3 (O395Y3N) or cheY-4 (O395Y4N) whereas alterations in motility or adherence were not observed for cheY-1 (O395Y1N) or cheY-2 (O395Y2N) insertional mutants. In contrast to O395Y1N and O395Y2N, O395Y3N and O395Y4N showed reduced cholera toxin production compared to wild-type in vitro. Infection of the human intestinal epithelial cell line Int407 with O395Y3N and O395Y4N caused reduced secretion of interleukin (IL)-1a, IL-6, tumor necrosis factor (TNF-a) and monocyte chemotactic protein-1 (MCP-1) compared to wild-type and was associated with delayed activation of nuclear factor kappa B (NF-B) p65 and its co-activator cAMP response element binding protein (CREB). Further, the absence of nuclear translocation of NF-B p50 subunit upon infection with O395Y3N or O395Y4N and its reversal upon complementation indicates the involvement of cheY-3 and cheY-4 in V. cholerae-induced pro-inflammatory response in the INT407 cell line.</p>]]></description>
<dc:creator><![CDATA[Bandyopadhaya, A., Chaudhuri, K.]]></dc:creator>
<dc:date>Wed, 27 May 2009 07:46:53 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425908100454</dc:identifier>
<dc:title><![CDATA[Differential modulation of NF-{kappa}B-mediated pro-inflammatory response in human intestinal epithelial cells by cheY homologues of Vibrio cholerae]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>142</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>131</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/3/143?rss=1">
<title><![CDATA[Rapid pulmonary fibrosis induced by acute lung injury via a lipopolysaccharide three-hit regimen]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/3/143?rss=1</link>
<description><![CDATA[<p>Based on the common characteristic of severe acute respiratory syndrome (SARS) and highly pathogenic avian influenza and the mechanism of inflammation and fibrosis, it is speculated that there should exist a fundamental pathological rule that severe acute lung injury (ALI)-induced rapid pulmonary fibrosis is caused by various etiological factors, such as SARS coronavirus, H5N1-virus, or other unknown factors, and also by lipopolysaccharide (LPS), the most common etiological factor. The investigation employed intratracheally, and intraperitoneally and intratracheally applied LPS three-hit regimen, compared with bleomycin-induced chronic pulmonary fibrosis. Inflammatory damage and fibrosis were evaluated, and the molecular mechanism was analyzed according to Th1/Th2 balance, Sma- and MAD-related proteins (Smads) and signal transducer and activator of transcriptions (STATs) expression. The results suggested that rapid pulmonary fibrosis could be induced by ALI via LPS three-hits. The period from 3&mdash;7 days in the LPS group was the first rapid pulmonary fibrosis stage, whereas the second fast fibrosis stage occurred on days 14&mdash;21. Th2 cell polarization, Smad4 and Smad7 should be the crucial molecular mechanism of ALI-induced rapid fibrosis. The investigation was not only performed to establish a new rapid pulmonary fibrosis model, but also to provide the elicitation for mechanism of ALI changed into the rapid pulmonary fibrosis.</p>]]></description>
<dc:creator><![CDATA[Hui Li,  , Shaohui Du,  , Lina Yang,  , Yangyan Chen,  , Wei Huang,  , Rong Zhang,  , Yinghai Cui,  , Jun Yang,  , Dongfeng Chen,  , Yiwei Li,  , Saixia Zhang,  , Jianhong Zhou,  , Zhijun Wei,  , Zhibin Yao,  ]]></dc:creator>
<dc:date>Wed, 27 May 2009 07:46:53 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425908101509</dc:identifier>
<dc:title><![CDATA[Rapid pulmonary fibrosis induced by acute lung injury via a lipopolysaccharide three-hit regimen]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>154</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>143</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/3/155?rss=1">
<title><![CDATA[Activation of Toll-like receptors 2 and 4 in Aspergillus fumigatus keratitis]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/3/155?rss=1</link>
<description><![CDATA[<p>Toll-like receptor (TLR) 2 and TLR4 are major receptors of Aspergillus fumigatus. Aspergillus fumigatus signaling in cornea induces the production of many pro-inflammatory molecules. In this study, we have shown that exposure of telomerase-immortalized human corneal epithelial cells (HCECs) to A. fumigatus antigens resulted in up-regulation of TLR2 and TLR4, and release of IL-1&beta; and IL-10 in HCECs, effects that could be inhibited by treatment with TLR2, and TLR4 antibodies. In addition, the A. fumigatus antigens-induced production of IL-1&beta; and IL-10 in supernatants of corneal epithelial cells was also attenuated by NF-B inhibitor. Aspergillus fumigatus keratitis developed in Wistar rats, as evidenced by high SLE scores, influx of polymorphonuclear leukocytes (PMNs), activation of TLR2 and TLR4, and production of IL-1&beta; and IL-10 over controls. These findings indicate that the cornea has functional TLR2 and TLR4, and activation of TLR2 and TLR4 through NF-B may contribute to pathogenesis of keratomycosis.</p>]]></description>
<dc:creator><![CDATA[Jie Zhao,  , Wu, X.-y., Yu, F.-S. X.]]></dc:creator>
<dc:date>Wed, 27 May 2009 07:46:53 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425908101521</dc:identifier>
<dc:title><![CDATA[Activation of Toll-like receptors 2 and 4 in Aspergillus fumigatus keratitis]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>168</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>155</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/3/169?rss=1">
<title><![CDATA[Activation of peroxisome proliferator-activated receptor-{gamma} potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/3/169?rss=1</link>
<description><![CDATA[<p>Our previous study demonstrated mRNA and protein expression of peroxisome proliferator-activated receptor-g (PPAR-g) in the immune system of weaned pigs. In this report, to test the hypothesis that activation of PPAR-g in immune system modulates inflammatory response, and adrenal and somatotropic responses associated with immune challenge, we administered intraperitoneally PPAR-g agonist and/or antagonist in weaned pigs subjected to Escherichia coli lipopolysaccharide (LPS) challenge. Unexpectedly, we found that a single injection of the PPAR-g agonist rosiglitazone (given at 3 mg/kg body weight 30 min before LPS injection) failed to block pro-inflammatory cytokine production induced by LPS injection. Rather, plasma levels of tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6), mRNA abundance of TNF-a in thymus, spleen, mesenteric lymph node and peripheral white blood cells, mRNA abundance of IL-6 in thymus, protein levels of TNF-a in spleen and mesenteric lymph node, and protein levels of IL-6 in spleen and mesenteric lymph node, were elevated beyond the levels in control pigs injected with LPS. Furthermore, rosiglitazone potentiated the increase of plasma cortisol and prostaglandin E<SUB>2</SUB> concentrations, and the decrease of plasma insulin-like growth factor-1 concentration induced by LPS injection. Co-administration of the PPAR-g antagonist bisphenol A diglycidyl ether (given 30 mg/kg body weight) 30 min prior to treatment with rosiglitazone antagonized the effect of the PPAR-g agonist, indicating a PPAR-g-dependent effect. Our data indicate that ligand-induced activation of PPAR-g does not ameliorate but enhances pro-inflammatory cytokine production, and further potentiates the adrenal and somatotropic changes in weaned pigs subjected to E. coli LPS challenge, which suggests that PPAR-g activation may not be useful, but potentially harmful, in the treatment of immune challenge in livestock. Our results raise doubts about the prevalently accepted anti-inflammatory role for PPAR-g activation.</p>]]></description>
<dc:creator><![CDATA[Yulan Liu,  , Junxia Shi,  , Jing Lu,  , Guoquan Meng,  , Huiling Zhu,  , Yongqing Hou,  , Yulong Yin,  , Shengjun Zhao,  , Binying Ding,  ]]></dc:creator>
<dc:date>Wed, 27 May 2009 07:46:53 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425908102014</dc:identifier>
<dc:title><![CDATA[Activation of peroxisome proliferator-activated receptor-{gamma} potentiates pro-inflammatory cytokine production, and adrenal and somatotropic changes of weaned pigs after Escherichia coli lipopolysaccharide challenge]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>178</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>169</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/3/179?rss=1">
<title><![CDATA[Review: Immunity mechanisms in crustaceans]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/3/179?rss=1</link>
<description><![CDATA[<p>Crustacean aquaculture represents a major industry in tropical developing countries. As a result of high culture densities and increasing extension of aquaculture farms, the presence of diseases has also increased, inducing economic losses. Invertebrates, which lack adaptive immune systems, have developed defense systems that respond against antigens on the surface of potential pathogens. The defense mechanisms of crustaceans depend completely on the innate immune system that is activated when pathogen-associated molecular patterns are recognized by soluble or by cell surface host proteins, such as lectins, antimicrobial, clotting, and pattern recognition proteins, which, in turn, activate cellular or humoral effector mechanisms to destroy invading pathogens. This work is aimed at presenting the main characteristics of the crustacean proteins that participate in immune defense by specific recognition of carbohydrate containing molecules, i.e. glycans, glycolipids, glycoproteins, peptidoglycans, or lipopolysaccharides from Gram-negative and Gram-positive bacteria, viruses, or fungi. We review some basic aspects of crustacean effector defense processes, like agglutination, encapsulation, phagocytosis, clottable proteins, and bactericidal activity, induced by these carbohydrate-driven recognition patterns.</p>]]></description>
<dc:creator><![CDATA[Vazquez, L., Alpuche, J., Maldonado, G., Agundis, C., Pereyra-Morales, A., Zenteno, E.]]></dc:creator>
<dc:date>Wed, 27 May 2009 07:46:53 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425909102876</dc:identifier>
<dc:title><![CDATA[Review: Immunity mechanisms in crustaceans]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>3</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>188</prism:endingPage>
<prism:publicationDate>2009-06-01</prism:publicationDate>
<prism:startingPage>179</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/2/67?rss=1">
<title><![CDATA[Invited review: Breaking barriers -- attack on innate immune defences by omptin surface proteases of enterobacterial pathogens]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/2/67?rss=1</link>
<description><![CDATA[<p>The omptin family of Gram-negative bacterial transmembrane aspartic proteases comprises surface proteins with a highly conserved &beta;-barrel fold but differing biological functions. The omptins OmpT of Escherichia coli, PgtE of Salmonella enterica, and Pla of Yersinia pestis differ in their substrate specificity as well as in control of their expression. Their functional differences are in accordance with the differing pathogenesis of the infections caused by E. coli, Salmonella, and Y. pestis, which suggests that the omptins have adapted to the life-styles of their host species. The omptins Pla and PgtE attack on innate immunity by affecting the plasminogen/plasmin, complement, coagulation, fibrinolysis, and matrix metalloproteinase systems, by inactivating antimicrobial peptides, and by enhancing bacterial adhesiveness and invasiveness. Although the mechanistic details of the functions of Pla and PgtE differ, the outcome is the same: enhanced spread and multiplication of Y. pestis and S. enterica in the host. The omptin OmpT is basically a housekeeping protease but it also degrades cationic antimicrobial peptides and may enhance colonization of E. coli at uroepithelia. The catalytic residues in the omptin molecules are spatially conserved, and the differing polypeptide substrate specificities are dictated by minor sequence variations at regions surrounding the catalytic cleft. For enzymatic activity, omptins require association with lipopolysaccharide on the outer membrane. Modification of lipopolysaccharide by in vivo conditions or by bacterial gene loss has an impact on omptin function. Creation of bacterial surface proteolysis is thus a coordinated function involving several surface structures.</p>]]></description>
<dc:creator><![CDATA[Haiko, J., Suomalainen, M., Ojala, T., Lahteenmaki, K., Korhonen, T. K.]]></dc:creator>
<dc:date>Tue, 24 Mar 2009 04:46:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425909102559</dc:identifier>
<dc:title><![CDATA[Invited review: Breaking barriers -- attack on innate immune defences by omptin surface proteases of enterobacterial pathogens]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>80</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>67</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/2/81?rss=1">
<title><![CDATA[Profile of the bovine acute-phase response following an intravenous bolus-dose lipopolysaccharide challenge]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/2/81?rss=1</link>
<description><![CDATA[<p>Our objective was to characterize further the acute-phase response following endotoxin (i.e. lipopolysaccharide; LPS) exposure in the bovine. Nine pure-bred Angus castrated males (i.e. steers; average body weight = 299 &plusmn; 5 kg) were used in a randomized complete block design in environmentally controlled chambers, set at thermoneutral level, to characterize the acute physiological, endocrine, immune, and acute-phase protein responses following an i.v. bolus administration of 2.5 &micro;g of LPS/kg body weight. One day before administration of LPS, all steers were fitted with an indwelling jugular vein catheter for serial blood collection. Blood samples were collected at 30-min intervals from -2 h to 8 h relative to the LPS challenge (time 0), and serum was harvested and stored at -80<sup> &deg;</sup>C until analyzed for concentrations of cortisol, pro-inflammatory cytokines, and acute-phase proteins. Indicators of thermal status (i.e. rectal temperature, ruminal temperature, respiration rate, sweat rate, and skin temperatures) were measured at 30-min intervals from -1 h to 6 h relative to the challenge. Endotoxin exposure increased (P&lt;0.05) serum concentrations of cortisol, tumor necrosis factor- (TNF-), interleukin 1-&beta; (IL-1&beta;), IL-6, interferon- (IFN-), and serum amyloid A. Respiration rate, rectal temperature, and rump skin temperature also were increased (P&lt;0.05) following LPS administration. Endotoxin exposure dramatically decreased ear skin temperature (P = 0.002), but tended to increase (P&lt;0.10) ruminal temperature, shoulder skin temperature, and shoulder sweat rate. Serum concentrations of acid soluble protein, -acid glycoprotein, IL-4 and IL-2, and rump sweat rate were not altered (P&gt;0.24) by the challenge. To our knowledge, this report is the most complete characterization of the bovine acute-phase response to a bolus-dose endotoxin challenge conducted under thermoneutral conditions and should provide foundation data for future research.</p>]]></description>
<dc:creator><![CDATA[Carroll, J. A., Reuter, R. R., Chase, C. C., Coleman, S. W., Riley, D. G., Spiers, D. E., Arthington, J. D., Galyean, M. L.]]></dc:creator>
<dc:date>Tue, 24 Mar 2009 04:46:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425908099170</dc:identifier>
<dc:title><![CDATA[Profile of the bovine acute-phase response following an intravenous bolus-dose lipopolysaccharide challenge]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>89</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>81</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/2/91?rss=1">
<title><![CDATA[Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/2/91?rss=1</link>
<description><![CDATA[<p>Cetuximab, an anti-epidermal growth factor receptor monoclonal antibody, has been shown to increase the median survival of colorectal cancer patients. We previously reported that the expression of HLA-E is significantly increased in primary human colorectal cancer, perhaps contributing to tumour escape from immune surveillance. To establish if HLA-E could be a factor that renders colorectal cancer cells less susceptible to antibody-dependent cellular cytotoxicity (ADCC), in the present study we analysed Cetuximab-mediated cytotoxicity against several colorectal cancer cell lines expressing, or not, HLA-E at the cell surface. We first observed that colorectal cancer cells treated with Cetuximab were killed more efficiently by ADCC. Interestingly, treatment of target cells with recombinant human-&beta;<SUB>2</SUB>-microglobulin inhibits Cetuximab-mediated ADCC through HLA-E membrane stabilization. The specific immunosuppressive role of HLA-E was confirmed using an anti-NKG2A monoclonal antibody, that restored the ability of immune cells to kill their target. This result demonstrates that HLA-E at the cell surface can reliably suppress the ADCC effect. On the other hand, Cetuximab induced a direct growth inhibition but only at high concentrations; furthermore, the CDC effect was quite moderate, and we failed to observe a pro-apoptotic effect. Taking into account that our findings suggest that ADCC activity is the main anti-tumour effect observed at clinically achievable concentrations of Cetuximab at the tumour site, we suggest that determination of HLA-E in colorectal cancer could be relevant to predict success of Cetuximab treatment.</p>]]></description>
<dc:creator><![CDATA[Levy, E. M., Sycz, G., Arriaga, J. M., Barrio, M. M., von Euw, E. M., Morales, S. B., Gonzalez, M., Mordoh, J., Bianchini, M.]]></dc:creator>
<dc:date>Tue, 24 Mar 2009 04:46:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425908101404</dc:identifier>
<dc:title><![CDATA[Cetuximab-mediated cellular cytotoxicity is inhibited by HLA-E membrane expression in colon cancer cells]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>100</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>91</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/2/101?rss=1">
<title><![CDATA[Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/2/101?rss=1</link>
<description><![CDATA[<p>Epidemiological studies suggest that intra-uterine exposure to inflammation may prime postnatal immune responses. In fetal sheep, intra-amniotic injection of lipopolysaccharide (LPS) induced chorioamnionitis, lung inflammation and maturation, matured lung monocytes to macrophages and initiated systemic tolerance of fetal monocytes to subsequent challenge with LPS. We hypothesized that LPS-mediated chorioamnionitis altered the response of lung and blood monocytes to Toll-like receptor (TLR) ligands such as PamCysK4 (TLR2), flagellin (TLR5), and human CpG-DNA (TLR9). Time-mated ewes were given intra-amniotic injections of LPS or saline. Blood and lung monocytes were assessed after 2 days, 7 days and 2 days and 7 days repetitive LPS injections before delivery at 124 days gestational age (term 150 days). Responsiveness of blood and lung monocytes to TLR-ligands in vitro was assessed by interleukin (IL)-6, tumor necrosis factor- (TNF-) and hydrogen peroxide. Monocytes from preterm controls had minimal responses. Lipopolysaccharide-mediated chorioamnionitis increased IL-6, TNF-  and hydrogen peroxide to all TLR agonists in blood and lung monocytes. Repetitive exposure to antenatal LPS reduced IL-6, TNF-  and hydrogen peroxide to TLR-ligands suggesting tolerance. Tolerance to TLR-ligands reduced IL-1 receptor associated kinase-4 expression. Thus, repeated fetal exposure to LPS induced tolerance to other TLR-ligands. These modulations of fetal innate immunity have implications for host defense and injury responses in preterm infants.</p>]]></description>
<dc:creator><![CDATA[Kramer, B. W., Kallapur, S. G., Moss, T. J., Nitsos, I., Newnham, J. P., Jobe, A. H.]]></dc:creator>
<dc:date>Tue, 24 Mar 2009 04:46:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425908100455</dc:identifier>
<dc:title><![CDATA[Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>107</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>101</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/2/109?rss=1">
<title><![CDATA[Calcineurin inactivation leads to decreased responsiveness to LPS in macrophages and dendritic cells and protects against LPS-induced toxicity in vivo]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/2/109?rss=1</link>
<description><![CDATA[<p>Microbial components such as lipopolysaccharide (LPS) bind to Toll-like receptors (TLRs) and activate innate and inflammatory responses. Responses to LPS and other microbial components are limited by the activation of negative feedback mechanisms that reduce responsiveness to subsequent LPS exposure, often termed LPS tolerance. Our laboratory has previously shown that calcineurin, a phosphatase known for its activation of T cells via NFAT, negatively regulates the TLR pathway in macrophages; consequently, calcineurin inhibitors (FK506 and cyclosporin A) mimic TLR ligands in activating the TLR pathway, NF-KB, and associated innate and inflammatory responses. This study investigated the physiological consequences of calcineurin inactivation for LPS-induced inflammatory responses in vitro and in vivo using two models: calcineurin inhibition by FK506 (tacrolimus) and myeloid cell-specific calcineurin deletion. Activation of dendritic cells and macrophages with FK506 in vitro was shown to induce a state of reduced responsiveness to LPS (i.e. a form of LPS tolerance). Similarly, macrophages from FK506-treated mice or from mice in which the calcineurin B1 (CnB1) subunit was conditionally knocked out in myeloid cells were found to have diminished LPS-induced inflammatory responses. In addition, mice with CnB1-deficient myeloid cells and mice undergoing FK506 treatment showed improved survival and recovery when challenged with high doses of systemic LPS compared to controls. These results demonstrate that inactivation of calcineurin in macrophages and other myeloid cells by inhibition or deletion can induce a form of LPS tolerance and protect the host from LPS toxicity in vivo.</p>]]></description>
<dc:creator><![CDATA[Jennings, C., Kusler, B., Jones, P. P.]]></dc:creator>
<dc:date>Tue, 24 Mar 2009 04:46:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425908100928</dc:identifier>
<dc:title><![CDATA[Calcineurin inactivation leads to decreased responsiveness to LPS in macrophages and dendritic cells and protects against LPS-induced toxicity in vivo]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>120</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>109</prism:startingPage>
<prism:section>Article</prism:section>
</item>

<item rdf:about="http://ini.sagepub.com/cgi/content/abstract/15/2/121?rss=1">
<title><![CDATA[Soluble CD14 in periodontitis]]></title>
<link>http://ini.sagepub.com/cgi/content/abstract/15/2/121?rss=1</link>
<description><![CDATA[<p>Lipopolysaccharide (LPS) binds to soluble (s)CD14. We investigated which factors contribute to variations in sCD14 levels in periodontitis, a chronic infectious disease of tooth-supporting tissues associated with endotoxemia and leading to inflammation and subsequently loss of teeth. The sCD14 levels were determined by ELISA in healthy controls (n = 57) and untreated patients (59 moderate and 46 severe) and their relation with markers of systemic inflammation (C-reactive protein levels, and leukocyte, neutrophil and lymphocyte counts) was assessed. Anti-Aggregatibacter actinomycetemcomitans and anti-Porphyromonas gingivalis IgG levels were established by ELISA and CD14<sup>-260</sup> genotype was determined in a TaqMan allelic discrimination assay. Increased levels of sCD14 were more frequent among periodontitis patients (P = 0.026) and showed a severity-dependence with increasing levels of periodontal breakdown (P = 0.008). In patients, levels of sCD14 correlated positively with CRP (P = 0.043), leukocyte numbers (P = 0.011) and negatively with anti-A. actinomycetemcomitans IgG (P = 0.007). In a multivariate analysis, sCD14 levels were predicted by ethnicity, age, educational level, and in Caucasian subjects also by the severity of periodontal destruction, but not by anti-P. gingivalis IgG or the CD14<sup>-260</sup> genotype. Periodontitis is associated with elevated levels of sCD14.</p>]]></description>
<dc:creator><![CDATA[Nicu, E. A., Laine, M. L., Morre, S. A., Van der Velden, U., Loos, B. G.]]></dc:creator>
<dc:date>Tue, 24 Mar 2009 04:46:05 PDT</dc:date>
<dc:identifier>info:doi/10.1177/1753425908101577</dc:identifier>
<dc:title><![CDATA[Soluble CD14 in periodontitis]]></dc:title>
<dc:publisher> International Endotoxin &amp; Innate Immunity Society</dc:publisher>
<prism:number>2</prism:number>
<prism:volume>15</prism:volume>
<prism:endingPage>128</prism:endingPage>
<prism:publicationDate>2009-04-01</prism:publicationDate>
<prism:startingPage>121</prism:startingPage>
<prism:section>Article</prism:section>
</item>

</rdf:RDF>